Market Tracker

05/29 8:58am ET

Array Biopharma Inc (NASDAQ:ARRY)

8.16
Delayed Data
As of May 26
 -0.11 / -1.33%
Today’s Change
3.10
Today|||52-Week Range
13.40
-7.17%
Year-to-Date
No recent news for Array Biopharma Inc.

Today’s Trading

Previous close8.27
Today’s open8.22
Day’s range8.10 - 8.25
Volume1,539,012
Average volume (3 months)4,098,384
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-1,028.57%
Earnings growth (this year)-17.44%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+165.62%
P/E ratioNM
Price/Sales3.69
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...+0.63+5.40%
RGENRepligen Corp+0.40+1.03%
INVAInnoviva Inc+0.08+0.66%
EBSEmergent BioSolution...+1.91+6.32%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateAugust 15, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$137.9M
Annual profit (last year)-$92.8M
Net profit margin-67.33%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ron Squarer
Chief Operating Officer
Andrew R. Robbins
Corporate headquarters
Boulder, Colorado

Forecasts